Literature DB >> 15238145

Impact of pre-analytical handling on bone marrow mRNA gene expression.

Stephen Breit1, Matthias Nees, Ulrike Schaefer, Margit Pfoersich, Christian Hagemeier, Martina Muckenthaler, Andreas E Kulozik.   

Abstract

Large clinical trials on leukaemia, require the transport of bone marrow (BM) from participating clinics to central diagnostic laboratories. We have investigated the impact of RNA extraction protocols and time delays between sample aspiration and RNA extraction on RNA quality and gene expression profiles. Intact RNA can be extracted from BM samples stored at room temperature for up to 48 h. Gene expression analyses using Affymetrix U95Av2 GeneChips and a custom-designed cDNA array in parallel showed that even short-term storage of BM has dramatic effects on mRNA expression of individual transcripts. Many probe sets/genes showed either reproducible deregulation (18.8%, analysis of variance <0.05), or inconsistent expression that differed from patient to patient (38.4%). Moderate alterations were observed in 42.8% genes, with a maximum fold change <2.0 in all experiments and at all time points. These profound effects complicate the use of unstabilized, shipped BM samples for gene expression analyses. The comparison of a variety of RNA stabilization reagents (e.g. PAXgene) resulted in partial conservation of the mRNA expression patterns. Immediate density centrifugation or erythrocyte lysis and freezing at -80 degrees C represent simple procedures that reliably preserved mRNA gene expression patterns in BM.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15238145     DOI: 10.1111/j.1365-2141.2004.05017.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  13 in total

Review 1.  Technical variables in high-throughput miRNA expression profiling: much work remains to be done.

Authors:  Peter T Nelson; Wang-Xia Wang; Bernard R Wilfred; Guiliang Tang
Journal:  Biochim Biophys Acta       Date:  2008-04-07

2.  Biospecimen reporting for improved study quality (BRISQ).

Authors:  Helen M Moore; Andrea B Kelly; Scott D Jewell; Lisa M McShane; Douglas P Clark; Renata Greenspan; Daniel F Hayes; Pierre Hainaut; Paula Kim; Elizabeth Mansfield; Olga Potapova; Peter Riegman; Yaffa Rubinstein; Edward Seijo; Stella Somiari; Peter Watson; Heinz-Ulrich Weier; Claire Zhu; Jim Vaught
Journal:  J Proteome Res       Date:  2011-06-21       Impact factor: 4.466

3.  Biospecimen Reporting for Improved Study Quality.

Authors:  Helen M Moore; Andrea Kelly; Scott D Jewell; Lisa M McShane; Douglas P Clark; Renata Greenspan; Pierre Hainaut; Daniel F Hayes; Paula Kim; Elizabeth Mansfield; Olga Potapova; Peter Riegman; Yaffa Rubinstein; Edward Seijo; Stella Somiari; Peter Watson; Heinz-Ulrich Weier; Claire Zhu; Jim Vaught
Journal:  Biopreserv Biobank       Date:  2011-04       Impact factor: 2.300

4.  Aberrant epigenetic and genetic marks are seen in myelodysplastic leukocytes and reveal Dock4 as a candidate pathogenic gene on chromosome 7q.

Authors:  Li Zhou; Joanna Opalinska; Davendra Sohal; Yiting Yu; Yongkai Mo; Tushar Bhagat; Omar Abdel-Wahab; Melissa Fazzari; Maria Figueroa; Cristina Alencar; Jinghang Zhang; Suman Kambhampati; Simrit Parmar; Sangeeta Nischal; Christoph Hueck; Masako Suzuki; Ellen Freidman; Andrea Pellagatti; Jacqueline Boultwood; Ulrich Steidl; Yogen Sauthararajah; Vijay Yajnik; Christine McMahon; Steven D Gore; Leonidas C Platanias; Ross Levine; Ari Melnick; Amittha Wickrema; John M Greally; Amit Verma
Journal:  J Biol Chem       Date:  2011-04-30       Impact factor: 5.157

5.  Unlocking the potential of publicly available microarray data using inSilicoDb and inSilicoMerging R/Bioconductor packages.

Authors:  Jonatan Taminau; Stijn Meganck; Cosmin Lazar; David Steenhoff; Alain Coletta; Colin Molter; Robin Duque; Virginie de Schaetzen; David Y Weiss Solís; Hugues Bersini; Ann Nowé
Journal:  BMC Bioinformatics       Date:  2012-12-24       Impact factor: 3.169

6.  The favorable effect of activating NOTCH1 receptor mutations on long-term outcome in T-ALL patients treated on the ALL-BFM 2000 protocol can be separated from FBXW7 loss of function.

Authors:  C Kox; M Zimmermann; M Stanulla; S Leible; M Schrappe; W-D Ludwig; R Koehler; G Tolle; O R Bandapalli; S Breit; M U Muckenthaler; A E Kulozik
Journal:  Leukemia       Date:  2010-10-14       Impact factor: 11.528

7.  Sources of variation in Affymetrix microarray experiments.

Authors:  Stanislav O Zakharkin; Kyoungmi Kim; Tapan Mehta; Lang Chen; Stephen Barnes; Katherine E Scheirer; Rudolph S Parrish; David B Allison; Grier P Page
Journal:  BMC Bioinformatics       Date:  2005-08-29       Impact factor: 3.169

8.  Screening and identification of differentially expressed transcripts in circulating cells of prostate cancer patients using suppression subtractive hybridization.

Authors:  Xin Li; Carson Wong; Ralph Mysel; Gennady Slobodov; Adam Metwalli; Jarrett Kruska; C Scott Manatt; Daniel J Culkin; Bradley P Kropp; Hsueh-Kung Lin
Journal:  Mol Cancer       Date:  2005-08-08       Impact factor: 27.401

9.  Quality control in microarray assessment of gene expression in human airway epithelium.

Authors:  Tina Raman; Timothy P O'Connor; Neil R Hackett; Wei Wang; Ben-Gary Harvey; Marc A Attiyeh; David T Dang; Matthew Teater; Ronald G Crystal
Journal:  BMC Genomics       Date:  2009-10-24       Impact factor: 3.969

10.  New data on robustness of gene expression signatures in leukemia: comparison of three distinct total RNA preparation procedures.

Authors:  Marta Campo Dell'Orto; Andrea Zangrando; Luca Trentin; Rui Li; Wei-min Liu; Geertruy te Kronnie; Giuseppe Basso; Alexander Kohlmann
Journal:  BMC Genomics       Date:  2007-06-22       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.